(Q43595673)

25 November 2017

Neurocysticercosis: an imported disease? (English)

1 reference

25 November 2017

1 reference

Terraza S

1

1 reference

25 November 2017

Pujol T

series ordinal

2

1 reference

25 November 2017

Gascón J

series ordinal

3

1 reference

25 November 2017

Corachán M

series ordinal

4

1 reference

25 November 2017

1 February 2001

1 reference

25 November 2017

1 reference

25 November 2017

116

1 reference

25 November 2017

7

1 reference

25 November 2017

261-263

1 reference

Cysticercosis as a major cause of epilepsy in Peru. The Cysticercosis Working Group in Peru (CWG)

25 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971790-3

Epilepsy due to neurocysticercosis: analysis of 203 patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971790-3

Recent advances in the diagnosis and treatment of cerebral cysticercosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971790-3

Discrepancies Between Cerebral Computed Tomography and Western Blot in the Diagnosis of Neurocysticercosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971790-3

Immunodiagnosis of Human Cysticercosis (Taenia solium): a Field Comparison of an Antibody-Enzyme-Linked Immunosorbent Assay (ELISA), an Antigen-ELISA, and an Enzyme-Linked Immunoelectrotransfer Blot (EITB) Assay in Peru

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971790-3

Immunodiagnosis of neurocysticercosis. Disappointing performance of serology (enzyme-linked immunosorbent assay) in an unbiased sample of neurological patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971790-3

Albendazole versus praziquantel in the treatment of cerebral cysticercosis: clinical evaluation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971790-3

Therapy for neurocysticercosis. Comparison between albendazole and praziquantel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971790-3

Single-day praziquantel versus 1-week albendazole for neurocysticercosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971790-3

Is the course of neurocysticercosis modified by treatment with antihelminthic agents?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971790-3

The course of seizures after treatment for cerebral cysticercosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971790-3

Discrepancies between cerebral computed tomography and western blot in the diagnosis of neurocysticercosis. The Cysticercosis Working Group in Peru (Clinical Studies Coordination Board).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971790-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0025-7753(01)71790-3

1 reference

25 November 2017

1 reference